Want to see NDRA full AI Analyst Report?
ENDRA Life Sciences (NDRA) Ratios
ENDRA Life Sciences Ratios
NDRA's free cash flow for Q2 2026 was $-946.23K. For the 2026 fiscal year, NDRA's free cash flow was decreased by $-18.67K and operating cash flow was $-927.56K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.29 | 5.67 | 3.36 | 5.00 | 7.83 |
| Quick Ratio | 1.29 | 5.67 | 3.36 | 3.45 | 7.00 |
| Cash Ratio | 1.02 | 5.34 | 3.14 | 2.87 | 6.13 |
| Solvency Ratio | -4.31 | -5.97 | -8.93 | -6.25 | -5.27 |
| Operating Cash Flow Ratio | -6.90 | -12.23 | -10.57 | -7.49 | -7.20 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -43.60 | -335.23 | -448.30 | -94.96 |
| Net Current Asset Value | $ -625.71K | $ 1.54M | $ 1.94M | $ 6.46M | $ 10.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.17 | 0.06 | 0.06 | 0.06 |
| Debt-to-Equity Ratio | 0.22 | 0.29 | 0.07 | 0.08 | 0.07 |
| Debt-to-Capital Ratio | 0.18 | 0.23 | 0.07 | 0.07 | 0.07 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.71 | 1.74 | 1.19 | 1.29 | 1.19 |
| Debt Service Coverage Ratio | 0.00 | -66.59 | -343.52 | -258.81 | -93.97 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -611.04 | 0.00 |
| Debt to Market Cap | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.63 | 0.67 | 0.23 | 0.29 | 0.39 |
| Net Debt to EBITDA | 0.04 | 0.22 | 0.25 | 0.34 | 0.79 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 121.94% | 106.39% | 95.62% | 100.16% | 97.68% |
| Return on Assets (ROA) | -182.35% | -258.47% | -148.95% | -142.11% | -87.24% |
| Return on Equity (ROE) | -310.93% | -449.46% | -177.77% | -182.93% | -104.14% |
| Return on Capital Employed (ROCE) | -185.74% | -281.17% | -179.81% | -173.80% | -101.48% |
| Return on Invested Capital (ROIC) | -178.30% | -262.95% | -173.80% | -169.75% | -99.29% |
| Return on Tangible Assets | -182.35% | -258.47% | -148.95% | -142.11% | -87.24% |
| Earnings Yield | -197.11% | -163.78% | -0.16% | -0.10% | -0.02% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.76 | 0.38 | 0.28 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.09 | 0.17 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -477.57 | 3164.14 | 802.70 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 4120.76 | 2089.30 |
| Days of Payables Outstanding | 0.00 | 0.00 | 477.57 | 956.62 | 1286.61 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 4120.76 | 2089.30 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -6.59 | -6.59 | -5.59 | -6.62 | -5.44 |
| Free Cash Flow Per Share | -6.61 | -6.61 | -5.61 | -6.72 | -5.46 |
| Dividend Paid and CapEx Coverage Ratio | -299.92 | -348.54 | -274.99 | -60.70 | -66.97 |
| Capital Expenditure Coverage Ratio | -299.92 | -462.53 | -281.81 | -63.03 | -247.16 |
| Operating Cash Flow Coverage Ratio | -10.53 | -9.81 | -24.21 | -23.36 | -13.97 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -145.85% | -105.55% | -0.15% | -0.09% | -0.02% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.51 | -0.61 | -629.86 | -1043.23 | -4411.18 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.58 | 2.74 | 1119.73 | 1908.36 | 4594.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.69 | -0.95 | -661.25 | -1059.89 | -4436.41 |
| Price-to-Operating Cash Flow Ratio | -0.69 | -0.95 | -663.60 | -1076.70 | -4454.36 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | -0.01 | -21.81 | 63.41 | 78.58 |
| Enterprise Value Multiple | -0.48 | -0.40 | -647.34 | -1061.77 | -4500.33 |
| Enterprise Value | 3.30M | 4.55M | 6.33B | 13.74B | 49.53B |
| EV to EBITDA | -0.48 | -0.40 | -647.34 | -1061.77 | -4500.33 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.63 | -0.61 | -661.00 | -1059.55 | -4435.63 |
| EV to Operating Cash Flow | -0.64 | -0.61 | -663.34 | -1076.36 | -4453.58 |
| Tangible Book Value Per Share | 2.87 | 2.28 | 3.31 | 3.73 | 5.27 |
| Shareholders’ Equity Per Share | 2.87 | 2.28 | 3.31 | 3.73 | 5.27 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -8.93 | -10.25 | -5.89 | -6.83 | -5.49 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.74 | 0.64 | 0.95 | 0.97 | 0.99 |
Currency in USD
